Wells Fargo & Company Enanta Pharmaceuticals Inc Transaction History

Wells Fargo & Company

  • $433 Billion
  • Q4 2024

A detailed history of Wells Fargo & Company transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Wells Fargo & Company holds 15,881 shares of ENTA stock, worth $123,554. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,881
Previous 9,363 69.61%
Holding current value
$123,554
Previous $97,000 6.19%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$5.75 - $12.99 $37,478 - $84,668
6,518 Added 69.61%
15,881 $91,000
Q3 2024

Nov 13, 2024
BUY
$10.05 - $16.54 $3,969 - $6,533
395 Added 4.4%
9,363 $97,000
Q2 2024

Aug 13, 2024
SELL
$11.43 - $17.02 $182,205 - $271,315
-15,941 Reduced 64.0%
8,968 $116,000
Q1 2024

May 10, 2024
BUY
$10.08 - $17.46 $188,808 - $327,043
18,731 Added 303.19%
24,909 $434,000
Q4 2023

Feb 09, 2024
BUY
$8.18 - $10.78 $9,816 - $12,936
1,200 Added 24.11%
6,178 $58,000
Q3 2023

Nov 13, 2023
SELL
$11.09 - $22.13 $216,310 - $431,645
-19,505 Reduced 79.67%
4,978 $55,000
Q2 2023

Aug 15, 2023
BUY
$20.68 - $39.85 $217,781 - $419,660
10,531 Added 75.48%
24,483 $523,000
Q1 2023

May 12, 2023
BUY
$38.82 - $54.59 $509,939 - $717,094
13,136 Added 1609.8%
13,952 $564,000
Q4 2022

Feb 13, 2023
SELL
$40.77 - $53.73 $42,604 - $56,147
-1,045 Reduced 56.15%
816 $37,000
Q3 2022

Nov 14, 2022
SELL
$48.29 - $71.27 $10,575 - $15,608
-219 Reduced 10.53%
1,861 $96,000
Q2 2022

Aug 12, 2022
SELL
$38.13 - $76.93 $556,850 - $1.12 Million
-14,604 Reduced 87.53%
2,080 $98,000
Q1 2022

May 16, 2022
SELL
$56.06 - $74.11 $317,243 - $419,388
-5,659 Reduced 25.33%
16,684 $1.19 Million
Q4 2021

Feb 14, 2022
BUY
$60.19 - $97.37 $411,398 - $665,523
6,835 Added 44.07%
22,343 $1.67 Million
Q3 2021

Nov 15, 2021
SELL
$41.02 - $58.65 $211,540 - $302,458
-5,157 Reduced 24.96%
15,508 $881,000
Q2 2021

Aug 16, 2021
BUY
$43.76 - $53.11 $720,639 - $874,615
16,468 Added 392.38%
20,665 $910,000
Q1 2021

May 13, 2021
SELL
$41.69 - $54.95 $1.59 Million - $2.09 Million
-38,047 Reduced 90.06%
4,197 $207,000
Q4 2020

Feb 09, 2021
BUY
$41.16 - $47.47 $68,696 - $79,227
1,669 Added 4.11%
42,244 $1.78 Million
Q3 2020

Nov 05, 2020
SELL
$43.36 - $53.53 $39,804 - $49,140
-918 Reduced 2.21%
40,575 $1.86 Million
Q2 2020

Aug 13, 2020
BUY
$46.37 - $57.58 $331,174 - $411,236
7,142 Added 20.79%
41,493 $2.08 Million
Q1 2020

May 14, 2020
BUY
$40.22 - $62.0 $1.38 Million - $2.13 Million
34,351 New
34,351 $1.77 Million

Others Institutions Holding ENTA

# of Institutions
108
Shares Held
19.7M
Call Options Held
9.7K
Put Options Held
12.4K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $161M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email